Polyisoprenol Specificity in the Campylobacter jejuni N-Linked Glycosylation Pathway
- 23 November 2007
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 46 (50) , 14342-14348
- https://doi.org/10.1021/bi701956x
Abstract
Campylobacter jejuni contains a general N-linked glycosylation pathway in which a heptasaccharide is sequentially assembled onto a polyisoprenyl diphosphate carrier and subsequently transferred to the asparagine side chain of an acceptor protein. The enzymes in the pathway function at a membrane interface and have in common amphiphilic membrane-bound polyisoprenyl-linked substrates. Herein, we examine the potential role of the polyisoprene component of the substrates by investigating the relative substrate efficiencies of polyisoprene-modified analogues in individual steps of the pathway. Chemically defined substrates for PglC, PglJ, and PglB are prepared via semisynthetic approaches. The substrates included polyisoprenols of varying length, double bond geometry, and degree of saturation for probing the role of the hydrophobic polyisoprene in substrate specificity. Kinetic analysis reveals that all three enzymes exhibit distinct preferences for the polyisoprenyl carrier whereby cis-double bond geometry and α-unsaturation of the native substrate are important features, while the precise polyisoprene length may be less critical. These findings suggest that the polyisoprenyl carrier plays a specific role in the function of these enzymes beyond a purely physical role as a membrane anchor. These studies underscore the potential of the C. jejuni N-linked glycosylation pathway as a system for investigating the biochemical and biophysical roles of polyisoprenyl carriers common to prokaryotic and eukaryotic glycosylation.Keywords
This publication has 44 references indexed in Scilit:
- Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled TrialsClinical Infectious Diseases, 2009
- Outcomes of early switching from intravenous to oral antibiotics on medical wardsJournal of Antimicrobial Chemotherapy, 2009
- Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure InfectionsInfection Control & Hospital Epidemiology, 2008
- In Vitro Biosynthesis of UDP-N,N‘-Diacetylbacillosamine by Enzymes of the Campylobacter jejuni General Protein Glycosylation SystemBiochemistry, 2006
- Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systemsProceedings of the National Academy of Sciences, 2006
- Definition of the bacterial N-glycosylation site consensus sequenceThe EMBO Journal, 2006
- Effectivity of dolichyl phosphates with different chain lengths as acceptors of nucleotide activated sugarsBioscience Reports, 1986
- A simple procedure for preparing dolichyl monophosphate by the use of POCl3FEBS Letters, 1981
- Hydrogenated polyprenol phosphates — exogenous lipid acceptors of glucose from UDP glucose in rat liver microsomesBiochemical and Biophysical Research Communications, 1975
- Sulphanilamide in the Treatment of ErysipelasBMJ, 1937